Search by Drug Name or NDC

    NDC 62332-0190-31 Febuxostat 40 mg/1 Details

    Febuxostat 40 mg/1

    Febuxostat is a ORAL TABLET, COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is FEBUXOSTAT.

    Product Information

    NDC 62332-0190
    Product ID 62332-190_d93f60e8-39b0-4359-9aaa-2e02ac188b1f
    Associated GPIs 68000030000320
    GCN Sequence Number 064829
    GCN Sequence Number Description febuxostat TABLET 40 MG ORAL
    HIC3 C7A
    HIC3 Description HYPERURICEMIA TX - XANTHINE OXIDASE INHIBITORS
    GCN 16808
    HICL Sequence Number 036106
    HICL Sequence Number Description FEBUXOSTAT
    Brand/Generic Generic
    Proprietary Name Febuxostat
    Proprietary Name Suffix n/a
    Non-Proprietary Name febuxostat
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 40
    Active Ingredient Units mg/1
    Substance Name FEBUXOSTAT
    Labeler Name Alembic Pharmaceuticals Inc.
    Pharmaceutical Class Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA205421
    Listing Certified Through 2024-12-31

    Package

    NDC 62332-0190-31 (62332019031)

    NDC Package Code 62332-190-31
    Billing NDC 62332019031
    Package 100 TABLET, COATED in 1 BOTTLE (62332-190-31)
    Marketing Start Date 2019-07-01
    NDC Exclude Flag N
    Pricing Information N/A